← FDA Drug Approvals (Drugs@FDA)
IBRANCE
NDA · New Drug Application · Sponsor: PFIZER · Approved 2015-02-03
Drug application
- FDA Application #
NDA207103- Application type
- New Drug Application
- Brand name
- IBRANCE
- Generic name
- PALBOCICLIB
- Active ingredients
- PALBOCICLIB
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PFIZER
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- First approval
- 2015-02-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown